Pituitary Suppression with Gonadotropin-Releasing Hormone Agonist Prior to Artificial Endometrial Preparation in Frozen-Thawed Embryo Transfer Cycles: A Systematic Review and Meta-Analysis of Different Protocols and Infertile Populations

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2024 Apr 27

PMID 38672116

Authors

Nguyen-Tuong Ho

Dang Khanh Ngan Ho

Xuan Hong Tomai

Nam Nhat Nguyen

Hung Song Nguyen

Yu-Ming Hu

Shu-Huei Kao

Chii-Ruey Tzeng

Affiliations

Soon will be listed here.

Abstract

This study investigates the effect of GnRHa pretreatment on pregnancy outcomes in artificial endometrial preparation for frozen-thawed embryo transfer (AC-FET) cycles. A systematic review of English language studies published before 1 September 2022, was conducted, excluding conference papers and preprints. Forty-one studies involving 43,021 participants were analyzed using meta-analysis, with a sensitivity analysis ensuring result robustness. The study found that GnRHa pretreatment generally improved the clinical pregnancy rate (CPR), implantation rate (IR), and live birth rate (LBR). However, discrepancies existed between randomized controlled trials (RCTs) and observational studies; RCTs showed no significant differences in outcomes for GnRHa-treated cycles. Depot GnRHa protocols outperformed daily regimens in LBR. Extended GnRHa pretreatment (two to five cycles) significantly improved CPR and IR compared to shorter treatment. Women with polycystic ovary syndrome (PCOS) saw substantial benefits from GnRHa pretreatment, including improved CPR and LBR and reduced miscarriage rates. In contrast, no significant benefits were observed in women with regular menstruation. More rigorous research is needed to solidify these findings.

References

van de Vijver A, Polyzos N, Van Landuyt L, De Vos M, Camus M, Stoop D . Cryopreserved embryo transfer in an artificial cycle: is GnRH agonist down-regulation necessary?. Reprod Biomed Online. 2014; 29(5):588-94. DOI: 10.1016/j.rbmo.2014.08.005. View

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

Wang Z, Wen Y, Xiong Y, Li Y, Huang J, Xu Y . Retrospective analysis of the endometrial preparation protocols for frozen-thawed embryo transfers in women with endometrial polyps. Hum Fertil (Camb). 2020; 25(3):534-539. DOI: 10.1080/14647273.2020.1855368. View

Nirgianakis K, Bersinger N, McKinnon B, Kostov P, Imboden S, Mueller M . Regression of the inflammatory microenvironment of the peritoneal cavity in women with endometriosis by GnRHa treatment. Eur J Obstet Gynecol Reprod Biol. 2013; 170(2):550-4. DOI: 10.1016/j.ejogrb.2013.08.010. View

Luo L, Chen M, Wen Y, Zhang L, Zhou C, Wang Q . Pregnancy outcome and cost-effectiveness comparisons of artificial cycle-prepared frozen embryo transfer with or without GnRH agonist pretreatment for polycystic ovary syndrome: a randomised controlled trial. BJOG. 2020; 128(4):667-674. DOI: 10.1111/1471-0528.16461. View

Siristatidis C, Arkoulis T, Christoforidis N, Salamalekis G, Koutlaki N, Karageorgiou V . Investigating the impact of different strategies for endometrial preparation in frozen cycles considering normal responders undergoing IVF/ICSI cycles: a multicenter retrospective cohort study. Syst Biol Reprod Med. 2021; 67(3):201-208. DOI: 10.1080/19396368.2021.1879967. View

Xu X, Deng S, Lian Z, Yu K . Estrogen Receptors in Polycystic Ovary Syndrome. Cells. 2021; 10(2). PMC: 7924872. DOI: 10.3390/cells10020459. View

Aghahoseini M, Alyasin A, Rashidi S, Samaei-Nouroozi A, Saeidi H, Shabani-Nashtaei M . The efficacy of gonadotropin-releasing hormone (GNRH) agonist before frozen embryo transfer in improving pregnancy outcome and decreasing miscarriage rate in hyperandrogenic polycystic ovary syndrome women: a randomized clinical trial. Minerva Ginecol. 2020; 72(4):212-218. DOI: 10.23736/S0026-4784.20.04467-6. View

Dong M, Sun L, Huang L, Yi Y, Zhang X, Tan Y . Gonadotropin-releasing hormone agonist combined with hormone replacement therapy does not improve the reproductive outcomes of frozen-thawed embryo transfer cycle in elderly patients: a retrospective study. Reprod Biol Endocrinol. 2020; 18(1):73. PMC: 7362427. DOI: 10.1186/s12958-020-00626-8. View

10.

Tsai H, Wang P, Lin L, Chen S, Tsui K . Using gonadotropin-releasing hormone agonist before frozen embryo transfer may improve ongoing pregnancy rates in hyperandrogenic polycystic ovary syndrome women. Gynecol Endocrinol. 2017; 33(9):686-689. DOI: 10.1080/09513590.2017.1307961. View

11.

Armijo-Olivo S, Stiles C, Hagen N, Biondo P, Cummings G . Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research. J Eval Clin Pract. 2010; 18(1):12-8. DOI: 10.1111/j.1365-2753.2010.01516.x. View

12.

Madani T, Ramezanali F, Yahyaei A, Hasani F, Bagheri Lankarani N, Mohammadi Yeganeh L . Live birth rates after different endometrial preparation methods in frozen cleavage-stage embryo transfer cycles: a randomized controlled trial. Arch Gynecol Obstet. 2019; 299(4):1185-1191. DOI: 10.1007/s00404-019-05062-7. View

13.

Pan D, Yang J, Zhang N, Wang L, Li N, Shi J . Gonadotropin-releasing hormone agonist downregulation combined with hormone replacement therapy improves the reproductive outcome in frozen-thawed embryo transfer cycles for patients of advanced reproductive age with idiopathic recurrent.... Reprod Biol Endocrinol. 2022; 20(1):26. PMC: 8812179. DOI: 10.1186/s12958-022-00897-3. View

14.

Li L, Liu L, Kou Z, Huo M, An J, Zhang X . GnRH agonist treatment regulates IL-6 and IL-11 expression in endometrial stromal cells for patients with HRT regiment in frozen embryo transfer cycles. Reprod Biol. 2022; 22(2):100608. DOI: 10.1016/j.repbio.2022.100608. View

15.

Schulte M, Tsai J, Moley K . Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation. Reprod Sci. 2014; 22(1):6-14. PMC: 4275454. DOI: 10.1177/1933719114561552. View

16.

Guo S, Li Z, Yan L, Sun Y, Feng Y . GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity. Drug Des Devel Ther. 2018; 12:1621-1631. PMC: 5995291. DOI: 10.2147/DDDT.S162541. View

17.

Sha T, Wang X, Cheng W, Yan Y . A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF. Reprod Biomed Online. 2019; 39(2):281-293. DOI: 10.1016/j.rbmo.2019.03.203. View

18.

Salemi S, Yahyaei A, Vesali S, Ghaffari F . Endometrial preparation for vitrified-warmed embryo transfer with or without GnRH-agonist pre-treatment in patients with polycystic ovary syndrome: a randomized controlled trial. Reprod Biomed Online. 2021; 43(3):446-452. DOI: 10.1016/j.rbmo.2021.06.006. View

19.

El-Toukhy T, Taylor A, Khalaf Y, Al-Darazi K, Rowell P, Seed P . Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles. A randomised study. Hum Reprod. 2004; 19(4):874-9. DOI: 10.1093/humrep/deh183. View

20.

Shalev E, Leung P . Gonadotropin-releasing hormone and reproductive medicine. J Obstet Gynaecol Can. 2003; 25(2):98-113. DOI: 10.1016/s1701-2163(16)30206-7. View